ORGS · As filed with the SEC
Orgenesis balance sheet, by quarter
The statement as Orgenesis presents it in its 10-Q and 10-K: its own lines, labels and order. Tables over time lines up standardized figures across every filing.
Consolidated Balance Sheets · USD thousands
| USD thousands | Q4 2024 Dec 31, 2024 | Q3 2024 Sep 30, 2024 | Q2 2024 Jun 30, 2024 | Q1 2024 Mar 31, 2024 |
|---|---|---|---|---|
| Assets | ||||
| CURRENT ASSETS: | ||||
| Cash and Cash Equivalents | 78 | 204 | 77 | 80 |
| Restricted Cash, Current | 609 | 918 | 1,079 | 485 |
| Accounts Receivable | 40 | 161 | 240 | 245 |
| Other Non-Operating Current Assets | 34 | 1,236 | 952 | 1,112 |
| Inventory | — | — | — | 34 |
| Total current assets | 761 | 2,519 | 2,348 | 1,956 |
| NON CURRENT ASSETS: | ||||
| Other Non-Current Assets | 12 | 55 | 249 | 255 |
| Investments to associates | — | 8 | 8 | — |
| Long-Term Investments | — | — | — | 8 |
| Property, Plant and Equipment | 578 | 14,901 | 15,901 | 16,404 |
| Intangible Assets | — | 8,528 | 8,724 | 8,950 |
| Operating Lease Right-of-Use Asset | — | 2,121 | 1,805 | 1,804 |
| Goodwill | — | 1,211 | 1,211 | 1,211 |
| Other Non-Operating Non-Current Assets | — | 344 | 331 | 332 |
| Total non-current assets | 590 | 27,168 | 28,229 | 28,964 |
| TOTAL ASSETS | 1,351 | 29,687 | 30,577 | 30,920 |
| Liabilities and equity | ||||
| CURRENT LIABILITIES: | ||||
| Short-Term Debt | 40 | — | — | — |
| Nonrelated Party | 10,428 | 11,338 | 10,717 | 13,707 |
| Related Party | 2,695 | 2,699 | 2,696 | 2,697 |
| Advance payments from Germfree (See note 11a) | — | 6,720 | 6,720 | — |
| Other Current Liabilities | 2,345 | 2,690 | 2,789 | 4,106 |
| Accrued Income Taxes | 781 | 784 | 767 | 786 |
| Accrued Compensation and Benefits | 2,122 | 1,853 | 1,634 | 1,529 |
| Advance payments on account of grant | 72 | 2,771 | 2,733 | 2,695 |
| Short-Term Debt | — | 4,905 | 1,186 | 626 |
| Short-Term Debt | 6,183 | — | — | — |
| Short-Term Debt | 25 | 46 | 62 | 65 |
| Operating Lease Liability, Current | 234 | 277 | 465 | 476 |
| Short-Term Debt | 1,995 | 1,966 | 1,931 | 2,344 |
| TOTAL CURRENT LIABILITIES | 26,920 | 36,049 | 31,700 | 29,031 |
| LONG-TERM LIABILITIES: | ||||
| Operating Lease Liability, Non-Current | 1,308 | 1,839 | 1,318 | 1,274 |
| Long-Term Debt | 2,895 | 2,828 | 2,762 | 2,696 |
| Convertible Debt, Non-Current | 5,578 | 5,435 | 5,296 | 20,336 |
| Pension and Post-Retirement Obligations | — | 101 | 96 | 98 |
| Finance Lease, Long-term leases obligations | 1 | 1 | 1 | 14 |
| Contingent liability (see note 4) | — | — | — | 4,643 |
| Contingent consideration (see note 4) | — | 4,906 | 4,825 | — |
| Other Non-Operating Non-Current Liabilities | 2,182 | 2,456 | 371 | 377 |
| TOTAL LONG-TERM LIABILITIES | 11,964 | 17,566 | 14,669 | 29,438 |
| TOTAL LIABILITIES | 38,884 | 53,615 | 46,369 | 58,469 |
| EQUITY (CAPITAL DEFICIENCY): | ||||
| Total Stockholders' Equity | 5 | 5 | 5 | 4 |
| Additional Paid-In Capital | — | 181,991 | 180,752 | 159,650 |
| Receipts on account of shares to be allotted | — | — | — | 155 |
| Additional Paid-In Capital | 188,163 | — | — | — |
| Accumulated Other Comprehensive Income | 384 | (215) | 302 | 126 |
| Treasury stock 286,567 shares as of December 31, 2024 and December 31, 2023 | (1,266) | (1,266) | (1,266) | (1,266) |
| Retained Earnings | (224,787) | (204,411) | (195,291) | (186,386) |
| Equity attributable to Orgenesis Inc. | (37,501) | (23,896) | (15,498) | (27,717) |
| Noncontrolling Interest | (32) | (32) | (294) | 168 |
| TOTAL EQUITY (CAPITAL DEFICIENCY) | (37,533) | (23,928) | (15,792) | (27,549) |
| TOTAL LIABILITIES, REDEEMABLE NON-CONTROLLING INTEREST AND EQUITY (CAPITAL DEFICIENCY) | 1,351 | 29,687 | 30,577 | 30,920 |
As filed on EDGAR · Not affiliated with the U.S. SEC · Not investment advice. Each column links to its filing.